Impact of preoperative maintenance or interruption of aspirin on thrombotic and bleeding events after elective non-cardiac surgery: The multicentre, randomized, blinded, placebo-controlled, STRATAGEM trial

British Journal of Anaesthesia

Volumn 107, Issue 6, 2011, Pages 899-910

  Mantz, J ^a,b,c   Samama, C M ^b,d   Tubach, F ^b,c,e   Devereaux, P J ^f   Collet, J P ^g,h   Albaladejo, P ^i,j   Cholley, B ^k   Nizard, R ^b,l   Barre J ^m   Piriou, V ⁿ   Poirier, N ^o   Mignon, A ^p   Schlumberger, S ^q   Longrois, D ^b,c,e   Aubrun, F ⁿ   Farese M E ^b,c,f   Ravaud, P ^b,c,d   Steg, P G ^b,c,e  

^a BEAUJON HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSERM   (France)

^d HÔTEL DIEU   (France)

^e BICHAT HOSPITAL   (France)

^f MCMASTER UNIVERSITY   (Canada)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^h SORBONNE UNIVERSITÉ   (France)

ⁱ GRENOBLE UNIVERSITY HOSPITAL   (France)

^j UNIV GRENOBLE ALPES   (France)

^k HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^l HÔPITAL LARIBOISIÈRE   (France)

^m REIMS UNIVERSITY HOSPITAL   (France)

ⁿ UNIVERSITÉ DE LYON   (France)

^o ANGERS UNIVERSITY HOSPITAL   (France)

^p Université Paris Descartes ^*  (France)

^q FOCH HOSPITAL   (France)

more..

Author keywords

aspirin interruption; bleeding events; non cardiac surgery; thrombotic events

Indexed keywords

ACETYLSALICYLIC ACID; PLACEBO;

ABDOMINAL SURGERY; AGED; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CONTROLLED STUDY; DRUG FATALITY; FEMALE; HUMAN; ISCHEMIA; LOW DRUG DOSE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MESENTERIC ISCHEMIA; ORTHOPEDIC SURGERY; PERIPHERAL ISCHEMIA; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SINGLE BLIND PROCEDURE; STROKE; SURGICAL RISK; THROMBOSIS; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; UROLOGIC SURGERY;

EID: 81855217382     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aer274     Document Type: Article

References (36)

1. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death myocardial infarction and stroke in high risk patients. Br Med J 2002; 324: 71-86
2. Biondi-Zoccai GG, Lotrionte M, Agostoni P, et al. A systematic review and meta-analysis of the hazards of discontinuing or not adhering to aspirin among 50,279 at risk for coronary artery disease. Eur Heart J 2006; 27: 2667-74
3. Rhee SJ, Yun KH, Lee SR, et al. Drug-eluting stents thrombosis during perioperative period. Int Heart J 2008; 49: 135-42
4. Mahla E, Lang T, Vincenzi MN, et al. Thromboelastography for monitoring prolonged hypercoagulability after major abdominal surgery. Anesth Analg 2001; 92: 572-7
5. Samama CM, Thiry D, Elalamy I, et al. Perioperative activation of hemostasis in vascular surgery patients. Anesthesiology 2001; 94: 74-8
6. Beving H, Zhao C, Albage A, Ivert T. Abnormally high platelet activity after discontinuation of acetylsalicylic acid treatment. Blood Coagul Fibrinolysis 1996; 7: 80-4
7. Schouten O, van Domburg RT, Bax JJ, et al. Noncardiac surgery after coronary stenting: early surgery and interruption of antiplatelet therapy are associated with an increase in major adverse cardiac events. J Am Coll Cardiol 2007; 49: 122-4
8. Pulmonary Embolism Prevention (PEP) Trial Collaborative Group. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 2000; 355: 1295-302
9. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 Guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary. Anesth Analg 2008; 106: 685-712
10. Grines CL, Bonow RO, Casey DE, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents. A Science Advisory from the American Heart Association, American College of Cardiology, Society of Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation 2007; 49: 734-9
11. Smout J, Stansby G. Current practice in the use of antiplatelet agents in the perioperative period by UK vascular surgeons. Ann R Coll Surg Engl 2003; 85: 97-101
12. Hiralal R, Guyatt G, Bhandari M, et al. A survey evaluating surgeons' perioperative usage of acetyl-salicylic acid (ASA) and their willingness to enroll their patients in a perioperative ASA randomized controlled trial. Clin Invest Med 2010; 33: E375-83
13. O'Riordan JM, Margey RJ, Blake G, O'Connell R. Antiplatelet agents in the perioperative period. Arch Surg 2009; 144: 69-76
14. Eberli D, Chassot PG, Sulser T, et al. Urological surgery and antiplatelet drugs after cardiac and cerebrovascular accidents. J Urol 2010; 183: 2128-36
15. Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery-executive summary. Circulation 2002; 105: 1257-67
16. Hirsch J, Guyatt G, Albers GW, Harrington R, Schünemann HJ. American College of Chest Physician. Antithrombotic and thrombolytic therapy: American College of Chest Physicians Evidence-Based Practice Guidelines (8th Edition). Chest 2008; 133: (6 Suppl): 110-2S
17. Samama CM, Bastien O, Forestier F, et al. Antiplatelet agents in the perioperative period: expert recommendations of the French Society of Anesthesiology and Intensive Care (SFAR)- 2001 summary statement. Can J Anaesth 2002; 49: S26-35
18. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: 381-453S
19. Estellat C, Tubach F, Costa Y, Hoffmann I, Mantz J, Ravaud P. Data capture by digital pen in clinical trials: a qualitative and quantitative study. Contemp Clin Trials 2008; 29: 314-23
20. Dechartres A, Albaladejo P, Mantz J, et al. Delphi consensus weights for ischemic and bleeding events to be included in a composite outcome for randomized controlled trials in thrombosis prevention. Plos ONE 2011; 6: E18461
21. Myles PS, Devereaux PJ. Pros and cons of composite endpoints in anaesthesia trials. Anesthesiology 2010; 113: 776-8
22. Neilipovitz DT, Bryson GL, Nichol G. The effect of perioperative aspirin therapy in peripheral vascular surgery: a decision analysis. Anesth Analg 2001; 93: 573-80
23. Albaladejo P, Geeraerts T, Francis F, Castier Y, Lesèche G, Marty J. Aspirin withdrawal and acute lower limb ischemia. Anesth Analg 2004; 99: 440-3
24. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing, 2010. Available from http://www.R-project.org
25. Ferrari E, Benhamou M, Cerboni P, Marcel B. Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis. J Am Coll Cardiol 2005; 45: 456-9
26. Collet JP, Montalescot G, Blanchet B, et al. Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes. Circulation 2004; 110: 2361-7
27. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. J Am Med Assoc 2005; 293: 2126-30
28. Oscarsson A, Gupta A, Fredrikson M, et al. To continue or discontinue aspirin in the perioperative period: a randomized, controlled, clinical trial. Br J Anaesth 2010; 104: 305-12
29. Landesberg G, Beattie WS, Mosseri M, Jaffe AS, Alpert JS. Perioperative myocardial infarction. Circulation 2009; 119: 2936-44
30. Guyatt GH, Cook DJ, Jaeschke R, Pauker SG, Schunemann HJ. Grades of recommendation for antithrombotic agents: AmericanCollege of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: 123-31S
31. Ferreira-Gonzá lez I, Busse JW, Heels-Ansdell D, et al. Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials. Br Med J 2007; 334: 76
32. Braunwald E, Cannon CP, McCabe CH. An approach to evaluating thrombolytic therapy in acute myocardial infarction. The 'unsatisfactory outcome' end point. Circulation 1992; 86: 683-7
33. Collyer TC, Gray DJ, Sandhu R, Berridge J, Lyons G. Assessment of platelet inhibition secondary to clopidogrel and aspirin therapy in preoperative acute surgical patients measured by thromboelastography platelet mapping. Br J Anaesth 2009; 102: 492-8
34. Zisman E, Erport A, Kohanovsky E, et al. Platelet function recovery after cessation of aspirin: preliminary study of volunteers and surgical patients. Eur J Anaesthesiol 2010; 27: 617-23
35. Patrono C, Rodriguez LAG, Landolfi R, Baigent C. Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med 2005; 353: 2373-83
36. Kim HL, Park KW, Kwak JJ, et al. Stent-related cardiac events after noncardiac surgery: drug-eluting stent vs bare-metal stent. Int J Cardiol 2008; 123: 353-4